---
schema_version: "secwatch.filing_event.v1"
accession: "0001818093-23-000004"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:34:16.644675+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BeautyHealth reports FY2022 net sales $365.9M (+41% YoY); guides FY2023 $450-470M

## Summary
- Full year net sales $365.9M (+41% YoY); Q4 net sales $98.1M (+26% YoY).
- Full year net income $44.4M vs net loss $375.1M in 2021; adjusted EBITDA $47.7M (+46% YoY).
- Guides FY2023 net sales $450-470M; affirms 18-20% adjusted EBITDA margin target.
- Confirms long-range 2025 guidance: net sales $600-700M, 25-30% adjusted EBITDA margin.
- Syndeo launch and China expansion key drivers; 8,492 delivery systems sold in 2022.

## SEC filing metadata
- accession: 0001818093-23-000004
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000181809323000004/0001818093-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000181809323000004/skin-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818093-23-000004
- JSON: https://secwatch.observer/filing/0001818093-23-000004.json
- Plain text: https://secwatch.observer/filing/0001818093-23-000004.txt

## Key facts
- Earnings Releases
  SkinHealth Systems Inc. reported the full year ended December 31, 2022 results: revenue $365.9 million, net income $44.4 million. Guidance reaffirmed.
  - Period: the full year ended December 31, 2022
  - Revenue: $365.9 million
  - Net income: $44.4 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Full year 2022 net sales of $365.9 million increased +41% relative to 2021, and fourth quarter net sales of $98.1 million increased +26%, revealing consistent mid-to-high double-digit quarterly growth year-over-year. The Company delivered net income of $44.4 million and adjusted EBITDA of $47.7 million for the full year, up +46% relative to 2021, and net income of $3.8 million and adjusted EBITDA of $16.3 million for the fourth quarter, up +92% relative to the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809323000004/0001818093-23-000004-index.htm
- Earnings Releases
  SkinHealth Systems Inc. reported the fourth quarter ended December 31, 2022 results: revenue $98.1 million, net income $3.8 million. Guidance reaffirmed.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $98.1 million
  - Net income: $3.8 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Full year 2022 net sales of $365.9 million increased +41% relative to 2021, and fourth quarter net sales of $98.1 million increased +26%, revealing consistent mid-to-high double-digit quarterly growth year-over-year. The Company delivered net income of $44.4 million and adjusted EBITDA of $47.7 million for the full year, up +46% relative to 2021, and net income of $3.8 million and adjusted EBITDA of $16.3 million for the fourth quarter, up +92% relative to the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809323000004/0001818093-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.